Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangdong Qiu

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Cancer Letters|October 1, 2023
Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatmentWenhao Luo, Jun Wang, Hao Chen, et al.
Cancer Letters|May 20, 2020
Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancerYueze Liu, Mengyu Feng, Hao Chen, et al.
Molecular Cancer|December 2, 2019
Role of the microbiome in occurrence, development and treatment of pancreatic cancerYicheng Wang, Gang Yang, Lei You, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2023
Prognostic value of preoperative [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristicsJie Ding, Jiangdong Qiu, Zhixin Hao, et al.
NPJ Precision Oncology|May 20, 2024
Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancerYifan Fu, Jinxin Tao, Yani Gu, et al.
Iscience|March 21, 2024
The NF-κB/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2/3Ruobing Wang, Dan Su, Yueze Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2023
Comparing the clinical value of baseline [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT and [<sup>18</sup>F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitisJie Ding, Jiangdong Qiu, Zhixin Hao, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 11, 2023
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerGuangyu Chen, Yueze Liu, Dan Su, et al.
Molecular Cancer|July 9, 2024
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancerYifan Fu, Jinxin Tao, Tao Liu, et al.
Cancer Research|May 22, 2024
FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and MetastasisDan Su, Ruobing Wang, Guangyu Chen, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Cancer Letters|October 1, 2023
Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatmentWenhao Luo, Jun Wang, Hao Chen, et al.
Cancer Letters|May 20, 2020
Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancerYueze Liu, Mengyu Feng, Hao Chen, et al.
Molecular Cancer|December 2, 2019
Role of the microbiome in occurrence, development and treatment of pancreatic cancerYicheng Wang, Gang Yang, Lei You, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2023
Prognostic value of preoperative [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristicsJie Ding, Jiangdong Qiu, Zhixin Hao, et al.
NPJ Precision Oncology|May 20, 2024
Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancerYifan Fu, Jinxin Tao, Yani Gu, et al.
Iscience|March 21, 2024
The NF-κB/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2/3Ruobing Wang, Dan Su, Yueze Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2023
Comparing the clinical value of baseline [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT and [<sup>18</sup>F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitisJie Ding, Jiangdong Qiu, Zhixin Hao, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 11, 2023
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerGuangyu Chen, Yueze Liu, Dan Su, et al.
Molecular Cancer|July 9, 2024
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancerYifan Fu, Jinxin Tao, Tao Liu, et al.
Cancer Research|May 22, 2024
FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and MetastasisDan Su, Ruobing Wang, Guangyu Chen, et al.
Pageof 6